Can Budesonide and Formoterol Inhalation Powder be used for nebulization?
Budesonide and formoterol fumarate inhalation powder is not suitable for nebulization therapy. This formulation is designed as a dry powder inhaler, with its composition, particle size, and release mechanism specifically tailored for use with dry powder inhalation devices. Nebulization requires specially formulated suspensions or solutions; using inappropriate formulations may result in ineffective drug nebulization, reduced therapeutic efficacy, and increased risk of adverse reactions. Seek medical attention promptly if discomfort occurs.

The dry powder formulation of this medication must be delivered directly to the airways via an inhalation device to exert its effect. In contrast, nebulization therapy requires liquid formulations (suspensions or solutions) that are converted into fine aerosol droplets by a nebulizer to meet the requirements for respiratory absorption. These two formulations differ fundamentally in characteristics and delivery devices and are not interchangeable.
When using this medication, strictly follow medical instructions and employ the correct dry powder inhalation technique to ensure adequate drug delivery to the target site. Monitor respiratory status during treatment, avoid exposure to irritants such as smoke and dust, maintain moist airways, and follow a regular作息 routine to improve physical health and enhance the effectiveness of drug therapy.